Eargo Inc. Stock News

908 Devices Inc. (MASS) delivered earnings and revenue surprises of 33.33% and 4.91%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Eargo Inc. (NASDAQ:EAR)’s traded shares stood at 0.68 million during the last session. At the last check today, the stock’s price was $4.10, to imply a decrease of -14.05% or -$0.67 in intraday trading. The EAR share’s 52-week high remains $62.47, putting it -1423.66% down since that peak but still an impressive -0.49% since price … What Could Change After Eargo Inc. (NASDAQ: EAR) Drops -0.49% From The High-Point? Read More »

In last trading session, Eargo Inc. (NASDAQ:EAR) saw 0.4 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.90 trading at $0.07 or 1.45% at ring of the bell on the day assigns it a market valuation of $198.74M. That closing price of EAR’s stock is at … Eargo Inc. (NASDAQ:EAR) Could Actually Go To $10.00 In 12 Months Read More »

LivaNova (LIVN) delivered earnings and revenue surprises of 14% and 2.54%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

An investigation on behalf of current long term investors in Eargo, Inc. (NASDAQ:EAR) shares over possible breaches of fiduciary duty by certain officers and directors was announced. San Diego, CA -- ( SBWIRE ) -- 02/18/2022 -- Certain directors of Eargo, Inc. are under investigation concerning potential breaches of fiduciary duties. Investors who are current long term investors in Eargo, Inc. (NASDAQ: EAR) shares, have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554. The investigation by a law firm for investors in NASDAQ: EAR stocks follows a lawsuit filed against Eargo, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: EAR stocks, concerns whether certain Eargo, Inc directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the Defendants failed to disclose to investors that Eargo had improperly sought reimbursements from certain third-party payors, that the foregoing was reasonably likely to lead to regulatory scrutiny, that, as a result and because the reimbursements at issue involved the Company''s largest third-party payor, Eargo''s financial results would be adversely impacted, and that as a result, Defendants'' statements about its business, operations, and prospects were materially false and misleading and/or lacked reasonable basis at all relevant times.

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 385.71% and 11.85%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Eargo Inc. (NASDAQ:EAR) concluded the trading at $5.07 on Friday, February 04 with a rise of 5.19% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $4.82 with its price kept floating in the range of $4.77 and $5.15 on the day. … Volatility Of Eargo Inc. (EAR) Reaches 7.56%: Make Sure To Keep Your Seat Tight! Read More »

SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the s

SAN JOSE, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- Eargo, Inc. (NASDAQ: EAR ), a medical device company on a mission to improve the quality of life of people with hearing loss, today announced the submission of public comments to the Food and Drug Administration (FDA) concerning its proposed rule to create a new regulatory category of over the counter (OTC) hearing aids. Eargo is supportive of the FDA''s proposed rule and applauds the FDA''s efforts to broaden consumer access to hearing technology. Historically, most people with hearing loss who would benefit from wearing a hearing aid have never used them, even though unaddressed hearing loss is associated with significant negative health outcomes and increased costs. 1 , 2 Eargo believes the FDA''s efforts to establish a regulatory framework for OTC hearing aids with appropriate measures to ensure consumer safety will help increase adoption of necessary hearing technology. Christian Gormsen, Eargo''s President and Chief Executive Officer, said, "Eargo was founded to create an affordable hearing aid that consumers actually want to use, and to offer a purchase experience that is accessible and empowering.

Eargo Inc (EAR) shares closed today 12.5% lower than it did at the end of yesterday. The stock is currently up 24.9% year-to-date, down 86.5% over the past 12 months, and down 81.1% over the past five years. Today, the Dow Jones Industrial Average fell 0.0%, and the S&P 500 fell 0.4%. Trading Activity Shares traded as high as $8.55 and as low as $4.54 this week.Shares closed 91.7% below its 52-week high and 41.9% above its 52-week low.Trading volume this week was 519.1% higher than the 10-day average and 1533.0% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.2. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -390.0% The company's stock price performance over the past 12 months lags the peer average by 529.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

The stock price of Eargo Inc (NASDAQ: EAR) increased by 59.65% today. This is why it happened.

Eargo has been making smart hearing aids for a while, but its sixth-generation device adds automatic sound adjustment depending on a users environment. It comes at a time where more companies are investing in sound boosting tech and the FDA has proposed a rule to establish a new over-the-counter hearing aid category to make the devices more accessible.

Eargo Inc (NASDAQ: EAR) traded significantly higher Thursday after the company announced the U.S. Department of Justice (DOJ) confirmed that its previously-announced criminal probe is no longer acti